- List
- By Topic
- On Map
- Search Details

testicular cancer | Recruiting, Not yet recruiting, Available Studies | Studies Without Results | Interventional Studies | ( Map: Italy ) | Adult
Need help? See RSS Feeds
Choose a feed type:

testicular cancer | Recruiting, Not yet recruiting, Available Studies | Studies Without Results | Interventional Studies | ( Map: Italy ) | Adult (4 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02478502 | Recruiting | Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
29 | Male | 18 Years and older (Adult, Older Adult) | NCT02478502 | 2012/1627 b 2012-004418-32 |
June 2015 | June 2019 | June 2019 | June 23, 2015 | November 5, 2018 |
|
|||
2 | NCT03391232 | Recruiting | PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry / Other |
|
|
15 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT03391232 | OBERTO 101 | OBERTO | April 9, 2018 | April 9, 2019 | December 21, 2019 | January 5, 2018 | September 26, 2018 |
|
||
3 | NCT03081923 | Recruiting | Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
120 | Male | 18 Years to 75 Years (Adult, Older Adult) | NCT03081923 | INT123-16 | APACHE | February 1, 2017 | February 2019 | August 2019 | March 16, 2017 | March 16, 2017 |
|
||
4 | NCT02375204 | Recruiting | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
|
420 | Male | 14 Years and older (Child, Adult, Older Adult) | NCT02375204 | A031102 U10CA180821 NCI-2014-01696 |
March 2015 | June 2024 | March 2, 2015 | January 24, 2019 |
|
† Study has passed its completion date and status has not been verified in more than two years.